» Articles » PMID: 16569911

Biomolecular Interactions by Surface Plasmon Resonance Technology

Overview
Specialty Public Health
Date 2006 Mar 30
PMID 16569911
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The Surface Plasmon Resonance (SPR) technique makes it possible to measure biomolecular interactions in real-time with a high degree of sensitivity and without the need of label. The information obtained is both qualitative and quantitative and it is possible to obtain the kinetic parameters of the interaction. This new technology has been used to study a diverse set of interaction partners of biological interest, such as protein-protein, protein-lipids, protein- nucleic acids or protein and low molecular weight molecules such as drugs, substrates and cofactors. In addition to basic biomedical research, the SPR biosensor has recently been used in food analysis, proteomics, immunogenicity and drug discovery.

Citing Articles

Toxic Peptides from the Mexican Scorpion : Chemical Structure and Evaluation of Recognition by Human Single-Chain Antibodies.

Riano-Umbarila L, Olamendi-Portugal T, Romero-Moreno J, Delgado-Prudencio G, Zamudio F, Becerril B Toxins (Basel). 2024; 16(7).

PMID: 39057941 PMC: 11280942. DOI: 10.3390/toxins16070301.


Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates.

Islam T, Kvartsberg H, Sehrawat A, Kac P, Becker B, Olsson M Alzheimers Dement. 2024; 20(4):2894-2905.

PMID: 38520322 PMC: 11032517. DOI: 10.1002/alz.13711.


Mass Spectrometry-Based Structural Proteomics for Metal Ion/Protein Binding Studies.

Lin Y, Gross M Biomolecules. 2022; 12(1).

PMID: 35053283 PMC: 8773722. DOI: 10.3390/biom12010135.


ERAP1 binds peptide C-termini of different sequences and/or lengths by a common recognition mechanism.

Sui L, Guo H Immunobiology. 2021; 226(4):152112.

PMID: 34247019 PMC: 8295233. DOI: 10.1016/j.imbio.2021.152112.


Molecular Interaction Characterization Strategies for the Development of New Biotherapeutic Antibody Modalities.

Wang X, Phan M, Li J, Gill H, Williams S, Gupta N Antibodies (Basel). 2020; 9(2).

PMID: 32218192 PMC: 7344756. DOI: 10.3390/antib9020007.